论文部分内容阅读
目的:对采用骨科体外震波治疗仪治疗运动员顽固性末端病进行疗效观察。方法:自2003年1月至2005年11月,采用体外震波仪治疗运动员网球肘、足跟痛、髌尖痛等共23例。治疗参数:电压14~16kV,频率2Hz,每个部位震波次数为1000~1500次。采用VAS评分评定治疗后的疼痛程度,“10”代表治疗前的疼痛,“0”代表不痛。VAS≤3为优,3~7之间为良,VAS≥7为差。结果:所有患者无明显不良反应。随访2周和3个月时,VAS分别为4·21±0·51和2·96±0·45,两者差异显著(P<0·05)。随访3~37个月,VAS评分优为64·29%,良为25·00%,差为10·71%。说明采用体外震波对本组病例顽固性末端病的治疗取得了一定疗效。
OBJECTIVE: To observe the therapeutic effect of orthopedics in vitro shock wave therapy on refractory terminal disease of athletes. Methods: From January 2003 to November 2005, 23 cases of athlete tennis elbow, heel pain and patellar pain were treated with an in vitro shock wave instrument. Treatment parameters: Voltage 14 ~ 16kV, frequency 2Hz, each part of the shock frequency 1000 ~ 1500 times. VAS score was used to assess the degree of pain after treatment, “10” represents the pain before treatment, “0” represents no pain. VAS ≤ 3 is excellent, between 3 and 7 is good, VAS ≥ 7 is poor. Results: All patients showed no adverse reactions. After 2 weeks and 3 months of follow-up, the VAS were 4.21 ± 0.51 and 2.96 ± 0.45, respectively (P <0.05). After 3 to 37 months of follow-up, the VAS score was 64.29%, with a good 25.00% and a difference of 10.71%. Description of the use of extracorporeal shock in this group of patients with refractory end of disease treatment has achieved some effect.